Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Human Microbiome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global human microbiome market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 18% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The human microbiome refers to the genes present inside various microorganisms found in the genetic portrait, or metagenome, of humans. It consists of various microorganisms, such as bacteria, fungi, protozoans, non-living viruses and numerous single-celled organisms. These organisms impact human physiology and contribute to the enhancement or impairment of metabolic and immune functions. They are found in the human tissues and are studied for medical advancements and analytical techniques. Microbiomes are utilized in probiotics, prebiotics, pharmaceutical drugs and diagnostic and therapeutic systems for various ailments, such as diabetes, obesity, cancer and metabolic, gastrointestinal, neurological, central nervous system and autoimmune disorders.

Human Microbiome Market Trends:

The increasing prevalence of chronic lifestyle diseases and infections due to microbial dysbiosis across the globe is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. The growth of the market can also be attributed to the increasing emphasis on the development of human microbiome therapeutics with enhanced efficacy. For instance, human gut microbiomes are being developed in specific combinations for the effective treatment of various gastrointestinal ailments. In line with this, the onset of the coronavirus (COVID-19) pandemic is also providing a thrust to the market growth. Researchers are extensively studying the lung microbiomes to analyze the severity of the infections and develop appropriate therapeutics and vaccines. Additionally, various advancements, such as the development of target-specific microbiome-based therapies, are also favoring the growth of the market. Other factors, including extensive research and development (R&D) activities, along with significant growth in the pharmaceutical industry, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global human microbiome market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, application and disease type.

Breakup by Product:

  • Probiotics
  • Prebiotics
  • Diagnostic Tests
  • Drugs
  • Medical Food
  • Others
     

Breakup by Application:

  • Therapeutics
  • Diagnostics
     

Breakup by Disease Type:

  • Obesity
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Gastrointestinal Disorders
  • Central Nervous System Disorders
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 4D pharma plc, Atlas Biomed Group Limited, BIOHM , BiomX , Bione , DayTwo Inc., ENTEROME , Ferring B.V., Finch Therapeutics, Second Genome Inc., SynBioBeta LLC, Synthetic Biologics Inc., Vedanta Biosciences Inc. and Viome Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Product, Application, Disease Type, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 4D pharma plc, Atlas Biomed Group Limited, BIOHM , BiomX , Bione , DayTwo Inc., ENTEROME , Ferring B.V., Finch Therapeutics, Second Genome Inc., SynBioBeta LLC, Synthetic Biologics Inc., Vedanta Biosciences Inc. and Viome Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global human microbiome market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global human microbiome market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the disease type?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global human microbiome market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Human Microbiome Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Probiotics
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Prebiotics
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Diagnostic Tests
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Drugs
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Medical Food
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Application
    7.1    Therapeutics
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Diagnostics
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Disease Type
    8.1    Obesity
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Diabetes
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Autoimmune Disorders
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Cancer
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Gastrointestinal Disorders
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Central Nervous System Disorders
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Others
        8.7.1 Market Trends
        8.7.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    4D pharma plc
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
        14.3.2    Atlas Biomed Group Limited
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    BIOHM 
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    BiomX 
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Bione 
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    DayTwo Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    ENTEROME 
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Ferring B.V.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Finch Therapeutics
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
        14.3.10    Second Genome Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
        14.3.11    SynBioBeta LLC
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
        14.3.12    Synthetic Biologics Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
        14.3.13    Vedanta Biosciences Inc.
           14.3.13.1 Company Overview
           14.3.13.2 Product Portfolio
        14.3.14    Viome Inc.
           14.3.14.1 Company Overview
           14.3.14.2 Product Portfolio

List of Figures

Figure 1: Global: Human Microbiome Market: Major Drivers and Challenges
Figure 2: Global: Human Microbiome Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: Human Microbiome Market: Breakup by Product (in %), 2020
Figure 5: Global: Human Microbiome Market: Breakup by Application (in %), 2020
Figure 6: Global: Human Microbiome Market: Breakup by Disease Type (in %), 2020
Figure 7: Global: Human Microbiome Market: Breakup by Region (in %), 2020
Figure 8: Global: Human Microbiome (Probiotics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Human Microbiome (Probiotics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Human Microbiome (Prebiotics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Human Microbiome (Prebiotics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Human Microbiome (Diagnostic Tests) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Human Microbiome (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Human Microbiome (Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Human Microbiome (Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Human Microbiome (Medical Food) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Human Microbiome (Medical Food) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Human Microbiome (Other Products) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Human Microbiome (Other Products) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Human Microbiome (Therapeutics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Human Microbiome (Therapeutics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Human Microbiome (Diagnostics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Human Microbiome (Diagnostics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Human Microbiome (Obesity) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Human Microbiome (Obesity) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Human Microbiome (Diabetes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Human Microbiome (Diabetes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Human Microbiome (Autoimmune Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Human Microbiome (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Human Microbiome (Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Human Microbiome (Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Human Microbiome (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Human Microbiome (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Human Microbiome (Central Nervous System Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Human Microbiome (Central Nervous System Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Global: Human Microbiome (Other Disease Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Global: Human Microbiome (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: North America: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: North America: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: United States: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: United States: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Canada: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Canada: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Asia-Pacific: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Asia-Pacific: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: China: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: China: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Japan: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Japan: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: India: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: India: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: South Korea: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: South Korea: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Australia: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Australia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Indonesia: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Indonesia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Others: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Europe: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Europe: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Germany: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Germany: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: France: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: France: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: United Kingdom: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: United Kingdom: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Italy: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Italy: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Spain: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Spain: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Russia: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Russia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Others: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Latin America: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Latin America: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Brazil: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Brazil: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Mexico: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Mexico: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Others: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Middle East and Africa: Human Microbiome Market: Sales Value (in Million US$), 2015 & 2020
Figure 85: Middle East and Africa: Human Microbiome Market: Breakup by Country (in %), 2020
Figure 86: Middle East and Africa: Human Microbiome Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Global: Human Microbiome Industry: SWOT Analysis
Figure 88: Global: Human Microbiome Industry: Value Chain Analysis
Figure 89: Global: Human Microbiome Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Human Microbiome Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Human Microbiome Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Human Microbiome Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: Human Microbiome Market Forecast: Breakup by Disease Type (in Million US$), 2021-2026
Table 5: Global: Human Microbiome Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Human Microbiome Market: Competitive Structure
Table 7: Global: Human Microbiome Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links